Financials
Financial year 2025
MGS Pharma from Stavelot, company number BE1014761540, closed financial year 2025 with a result of € 54,885 after tax. For that financial year MGS Pharma recorded a gross margin of € 69,967 and equity of € 54,552. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 24, 2026.
€ 54,552
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 54,885
Profit after tax over the fiscal year.
€ 63,690
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
2 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 790
Supplier invoices still open on the last day of the fiscal year.
€ 12,027
Taxes, VAT and social contributions still to pay.
Ask about MGS Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MGS Pharma?
What happened at MGS Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 54,885. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Stavelot. KBO
- Louise MAGIS became a director. NBB
In short
Paid € 14,994 in corporate taxes since 2025.
Paid out € 833 in dividends to the owners in total.
Management
Behind MGS Pharma is Louise MAGIS.
Directors
According to the 2025 annual accounts
Louise MAGIS
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Rue des Longues Pièces 17
4970 Stavelot
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Stavelot
Same main activity (Detailhandel in farmaceutische producten), 3 active companies in Stavelot, largest first.
€ 553,685 gross margin · 2025
€ 50,288 gross margin · 2025
€ 26,238 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- MAGIS Louise Anne Marie(oprichter) 100%
Details
- Company number
- 1014.761.540
- VAT number
- BE 1014.761.540
- Registered office
- Rue des Longues Pièces 17, 4970 Stavelot
- Names & denominations
- MGS Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 October 2024
- Peppol
- Active · Active since 18 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Overige zakelijke dienstverlening, neg